SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:27dbf388-213f-47ad-a13e-ccce5923379d"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:27dbf388-213f-47ad-a13e-ccce5923379d" > Use of terbinafine ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003935naa a2200397 4500
001oai:lup.lub.lu.se:27dbf388-213f-47ad-a13e-ccce5923379d
003SwePub
008181123s2019 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/27dbf388-213f-47ad-a13e-ccce5923379d2 URI
024a https://doi.org/10.1002/ijc.319012 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Ji, Jianguangu Lund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,Family Medicine and Clinical Epidemiology,Lund University Research Groups,Region Skåne4 aut0 (Swepub:lu)med-jji
2451 0a Use of terbinafine and risk of death in patients with prostate cancer : A population-based cohort study
264 c 2018-11-04
264 1b Wiley,c 2019
520 a Terbinafine is used for the treatment of several superficial fungal infections. In silico analyses and animal models suggest that terbinafine might have an anti-tumor effect. We aimed to explore whether subsequent administration of terbinafine might be associated with a lower mortality rate in patients with prostate cancer. We identified patients diagnosed with prostate cancer between July 2005 and December 2014 from the Swedish Cancer Registry, and linked them to the Swedish Prescribed Drug Register to ascertain subsequent use of terbinafine. A total of 799 patients received oral treatment of terbinafine during the study period with a mortality rate of 18.6 per 1,000 person-years. Compared to patients who did not use terbinafine and adjusting for a range of confounding factors, patients that received oral treatment of terbinafine had a decreased risk of death from prostate cancer (HR, 0.53; 95% CI, 0.38–0.73) and a decreased risk of death overall (HR, 0.64; 95% CI, 0.52–0.77). To account for indication bias, we further identified 907 patients who received topical use of terbinafine. However, the risk of death from prostate cancer in patients with topical use of terbinafine was 0.92 (95% CI 0.74–1.12) and the risk of death overall was 1.03 (95% CI 0.91–1.17) as compared to the controls, which suggests that there was no association between risk of death in patients with prostate cancer with topical use of terbinafine. These findings suggest that this drug's potential anti-tumor effect needs to be explored further.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a cohort study
653 a cox-regression
653 a epidemiology
653 a mortality
653 a prostate cancer
653 a register-based study
653 a terbinafine
700a Sundquist, Janu Lund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,Family Medicine and Clinical Epidemiology,Lund University Research Groups,Icahn School of Medicine at Mount Sinai,Region Skåne4 aut0 (Swepub:lu)med-jsu
700a Sundquist, Kristinau Lund University,Lunds universitet,Allmänmedicin, kardiovaskulär epidemiologi och levnadsvanor,Forskargrupper vid Lunds universitet,Family Medicine, Cardiovascular Epidemiology and Lifestyle,Lund University Research Groups,Icahn School of Medicine at Mount Sinai,Region Skåne4 aut0 (Swepub:lu)med-ksq
710a Allmänmedicin och klinisk epidemiologib Forskargrupper vid Lunds universitet4 org
773t International Journal of Cancerd : Wileyg 144:8, s. 1888-1895q 144:8<1888-1895x 0020-7136x 1097-0215
856u http://dx.doi.org/10.1002/ijc.31901y FULLTEXT
8564 8u https://lup.lub.lu.se/record/27dbf388-213f-47ad-a13e-ccce5923379d
8564 8u https://doi.org/10.1002/ijc.31901

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Ji, Jianguang
Sundquist, Jan
Sundquist, Krist ...
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Cancer och onkol ...
Artiklar i publikationen
International Jo ...
Av lärosätet
Lunds universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy